These results convincingly demonstrate that NFκB specifically binds to its above-mentioned cognate motifs on hnRNPD promoter in oral cancer cells SCC-4 cells in-vivo and this binding is dramatically reduced/abrogated by PDTC treatment. Here, NFKB1 is linked to lip and oral cavity carcinoma.